Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 9, 2017 - Issue
Submit an article Journal homepage
227
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Sandra Jernström1 Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital;2 KG Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
,
Vesa Hongisto3 Misvik Biology Oy, Turku
,
Suvi-Katri Leivonen1 Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital;2 KG Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
,
Eldri Undlien Due1 Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital
,
Dagim Shiferaw Tadele1 Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital
,
Henrik Edgren4 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki;5 Medisapiens, Helsinki, Finland
,
Olli Kallioniemi4 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki
,
Merja Perälä6 VTT Technical Research Centre of Finland, Turku, Finland
,
Gunhild Mari Mælandsmo2 KG Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway;7 Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway;8 Institute of Pharmacy, Faculty of Health Sciences, University of Tromsø, Tromsø
&
Kristine Kleivi Sahlberg1 Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital;9 Department of Research, Vestre Viken Hospital Trust, Drammen, NorwayCorrespondence[email protected]
 show all
Pages 185-198 | Published online: 21 Mar 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lisa Svartdal Normann, Mads Haugland Haugen, Miriam Ragle Aure, Vessela N Kristensen, Gunhild Mari Mælandsmo & Kristine Kleivi Sahlberg. (2022) miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy. Breast Cancer: Targets and Therapy 14, pages 25-39.
Read now

Articles from other publishers (8)

G. Gambardella, G. Viscido, B. Tumaini, A. Isacchi, R. Bosotti & D. di Bernardo. (2022) A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response. Nature Communications 13:1.
Crossref
János Tibor Fekete & Balázs Győrffy. (2022) A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines. Computational and Structural Biotechnology Journal 20, pages 2885-2894.
Crossref
Dhania NovitasariRiris Istighfari JenieFebri WulandariRohmad Yudi UtomoDyaningtyas Dewi Pamungkas PutriJun-ya KatoEdy Meiyanto. (2021) Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1. Research Journal of Pharmacy and Technology, pages 4375-4382.
Crossref
Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo & Kristine Kleivi Sahlberg. (2021) MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro. Scientific Reports 11:1.
Crossref
Anastasia Kapara, Karla A. Findlay Paterson, Valerie G. Brunton, Duncan Graham, Michele Zagnoni & Karen Faulds. (2021) Detection of Estrogen Receptor Alpha and Assessment of Fulvestrant Activity in MCF-7 Tumor Spheroids Using Microfluidics and SERS. Analytical Chemistry 93:14, pages 5862-5871.
Crossref
William D. Gwynne, Mirza S. Shakeel, Jianhan Wu, Robin M. Hallett, Adele Girgis-Gabardo, Anna Dvorkin-Gheva & John A. Hassell. (2019) Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells. Cellular & Molecular Biology Letters 24:1.
Crossref
Tayebeh Saleh, Tooba Soudi & Seyed Abbas Shojaosadati. (2019) Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells. International Journal of Biological Macromolecules 130, pages 109-116.
Crossref
Takuro Yamamoto, Noriko Kanaya, George Somlo & Shiuan Chen. (2019) Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer. Breast Cancer Research and Treatment 174:3, pages 615-625.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.